MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study-Reference-Cited by-同舟云学术

MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study

Published:2017-02 Issue:2 Volume:18 Page:192-201
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Hickish Tamas,Andre Thierry,Wyrwicz Lucjan,Saunders Mark,Sarosiek Tomasz,Kocsis Judit,Nemecek Radim,Rogowski Wojciech,Lesniewski-Kmak Krzysztof,Petruzelka Lubos,Apte Ron N,Mohanty Prasant,Stecher Michael,Simard John,de Gramont Aimery

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet,2012

2. Incidence and patterns of recurrence following curative resection for colorectal carcinoma;Obrand;Dis Colon Rectum,1997

3. Interleukin-1α neutralisation in patients with cancer;Dinarello;Lancet Oncol,2014

4. Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts;Tjomsland;Neoplasia,2011

5. Significant correlation between expression of interleukin-1α and liver metastasis in gastric carcinoma;Tomimatsu;Cancer,2001

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-30

2. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

3. IL-1α facilitates GSH synthesis to counteract oxidative stress in oral squamous cell carcinoma under glucose-deprivation;Cancer Letters;2024-05

4. Transcriptomic and spatial dissection of human ex vivo right atrial tissue reveals proinflammatory microvascular changes in ischemic heart disease;Cell Reports Medicine;2024-05

5. New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer;Pharmacological Research;2024-02